Economic Atlas
Companies/Bausch Health Companies Inc.
Company profile

Bausch Health Companies Inc.

NYSE: BHC · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Laval, QCCIK 0000885590Reports USD
#41 of 1,418 Healthcare companies by revenue51st-percentile growth
EA Score
82B+
Revenue TTM
$10.6B
Rev growth YoY (TTM)
+8.5%
Net income (FY)
$157.0M
Employees
20,300
as of 2026-08-09
Market cap
$2.3B
as of 2026-08-09

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$10.3B$10.3B2025
Net income$157.0M$157.0M2025
Operating income$1.8B$1.8B2025
Total assets$26.4B$26.4B2025
Liabilities$26.0B$26.0B2025
Equity-$554.0M-$554.0M2025

Revenue trend

FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product49%
Pharmaceutical Products23%
Device Products12%
Over the Counter Products10%
Branded and Other Generic Products5%
Other Revenues1%
By geography
United States and Puerto Rico62%
Other Countries12%
CHINA5%
CANADA4%
POLAND4%
MEXICO3%
The read

What is Bausch Health Companies Inc.’s revenue?

Bausch Health Companies Inc. booked $10.3B in FY2025 revenue, growing 6.7% year over year — about the middle of the pack among Healthcare companies we track, at a 1.5% net margin.

Peers · Healthcare
Vertex Pharmaceuticals Incorporated88ABaxter International Inc.78B+Quest Diagnostics Incorporated88AIntuitive Surgical, Inc.90ABiogen Inc.85AZoetis Inc.82B+
Key facts
CEOThomas J. Appio
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLaval, QC
ExchangeNYSE: BHC
Employees20,300
IPO date1994-03-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.